Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate

Journal of Urology

Volumn 175, Issue 3, 2006, Pages 923-928

  Lopez Corona, Ernesto ^a,c   Ohori, Makoto ^a,d   Wheeler, Thomas M ^b   Reuter, Victor E ^a   Scardino, Peter T ^a   Kattan, Michael W ^a,e   Eastham, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biopsy; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHEMICAL ANALYSIS; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; SEMINAL VESICLE; TUMOR VOLUME;

EID: 32044454875     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00350-2     Document Type: Article

References (18)

1. B. Djavan, A. Zlotta, M. Remzi, K. Ghawidel, A. Basharkhah, C.C. Schulman Optimal predictors of prostate cancer on repeat prostate biopsy a prospective study of 1,051 men J Urol 163 2000 1144
2. K.G. Fink, G. Hutarew, W. Lumper, A. Jungwirth, O. Dietze, N.T. Schmeller Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies Urology 58 2001 735
3. S.R. Potter, W. Horniger, M. Tinzl, G. Bartsch, A.W. Partin Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer Urology 57 2001 1100
4. H.B. Carter, J.D. Pearson, E.J. Metter, L.J. Brant, D.W. Chan, R. Andres Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 1992 2215
5. W.J. Catalona, A.W. Partin, K.M. Slawin, M.K. Brawer, R.C. Flanigan, A. Patel Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease a prospective multicenter clinical trial JAMA 279 1998 1542
6. G.J. O'dowd, M.C. Miller, R. Orozco, R.W. Veltri Analysis of repeated biopsy results within 1 year after a noncancer diagnosis Urology 55 2000 553
7. R.C. Ouyang, D.N. Kenwright, J.N. Nacey, B. Delahunt The presence of atypical small acinar proliferation in prostate needle biopsy is predictive of carcinoma on subsequent biopsy BJU Int 87 2001 70
8. S. Park, K. Shinohara, G.D. Grossfeld, P.R. Carroll Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy J Urol 165 2001 1409
9. B. Djavan, V. Ravery, A. Zlotta, P. Dobronski, M. Dobrovits, M. Fakhari Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4 when should we stop? J Urol 166: 2001 1679
10. J.I. Epstein, P.C. Walsh, G. Akingba, H.B. Carter The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer J Urol 162 1999 1649
11. M. Ohori, T.M. Wheeler, P.T. Scardino The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer Clinicopathologic correlations Cancer 74 1994 104
12. T.M. Wheeler Anatomy and pathology of prostate cancer chapt. 36 N.J. Vogelzang P.T. Scardino W.U. Shipley D.S. Coffey Comprehensive Textbook of Genitourinary Oncology 2nd ed. 2000 Lippincott Williams & Wilkins Philadelphia 587
13. F. Rabbani, A. Bastar, W.R. Fair Site specific predictors of positive margins at radical prostatectomy an argument for risk based modification of technique J Urol 160 1998 1727
14. M. Ohori, T.M. Wheeler, J.K. Dunn, T.A. Stamey, P.T. Scardino The pathological features and prognosis of prostate cancer detectable with current diagnostic tests J Urol 152 1994 1714
15. J.I. Epstein, P.C. Walsh, J. Sauvageot, H.B. Carter Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer J Urol 158 1997 1886
16. Y. Goto, M. Ohori, A. Arakawa, M.W. Kattan, T.M. Wheeler, P.T. Scardino Distinguishing clinically important from unimportant prostate cancers before treatment value of systematic biopsies J Urol 156 1996 1059
17. D.J. Grossklaus, C.S. Coffey, S.B. Shappell, G.S. Jack, M.S. Cookson Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores BJU Int 88 2001 722
18. M.E. Chen, P. Troncoso, D. Johnston, K. Tang, R.J. Babaian Prostate cancer detection relationship to prostate size Urology 53: 1999 764